LIGAND PHARMACEUTICALS INC — Investor Relations & Filings
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-18 | English | |
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-08 | English | |
| 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46385520 | DEFA14A | 2026-05-18 | English | ||
| 46385526 | 8-K | 2026-05-18 | English | ||
| 46155763 | 10-Q | 2026-05-08 | English | ||
| 42834703 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | ||
| 46155787 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155789 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155782 | 8-K | 2026-04-30 | English | ||
| 46155792 | DEFA14A | 2026-04-27 | English | ||
| 37461463 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-27 | English | ||
| 46155795 | ARS | 2026-04-21 | English | ||
| 46155796 | DEFA14A | 2026-04-21 | English | ||
| 34907767 | DEF 14A - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-21 | English | ||
| 33067636 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067397 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067331 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
Market data
Market data not available
Price history
Peer group · Other financial service activities n.e.c., except insurance and pension funding activities
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Gores Holdings X, Inc. / CI
A blank check company formed to effect a merger or similar …
|
GTEN | US | Financial and insurance activit… |
|
GP-Act III Acquisition Corp.
A SPAC formed to merge with a high-quality, billion-dollar-…
|
GPAT | US | Financial and insurance activit… |
|
GPM Vindexus S.A.
Financial services firm specializing in debt portfolio mana…
|
VIN | PL | Financial and insurance activit… |
|
Grande Group Ltd/HK
A boutique financial firm providing corporate finance and I…
|
GRAN | US | Financial and insurance activit… |
|
GreenBank Capital Inc.
Merchant banking and corporate finance investment firm focu…
|
GBC | CA | Financial and insurance activit… |
|
Greencrest Financial Services Limited
Provides credit facilities and manages investment portfolio…
|
531737 | IN | Financial and insurance activit… |
|
Greenpro Capital Corp.
A business incubator and advisory firm providing financial …
|
GRNQ | US | Financial and insurance activit… |
|
Grosvenor CPC I Inc.
A capital pool company identifying assets or businesses to …
|
GRVA.P | CA | Financial and insurance activit… |
|
GROUP ONE CAPITAL LIMITED
Strategic investment firm focused on capital allocation and…
|
G1C | KY | Financial and insurance activit… |
|
Group Pacific Capital Inc.
Strategic wealth management and business consulting for hig…
|
3721Z | CA | Financial and insurance activit… |
LIGAND PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31289/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31289 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31289 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31289 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31289}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LIGAND PHARMACEUTICALS INC (id: 31289)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.